A2 BioPharm Collaborative

Three Companies. One Solution.

The A2 BioPharm Collaborative brings together three Michigan-based organizations with deep scientific expertise and a shared commitment to advancing pharmaceutical innovation. By combining chemistry, biology, and preclinical development under one integrated model, we support seamless progress from early discovery through IND-enabling studies.

Together, AnchorBio, AAPharmaSyn, and TSRL form a multidisciplinary partnership that helps Sponsors move with confidence through the preclinical landscape.

 

Integrated Support Across the Drug Development Continuum

We provide coordinated expertise to streamline the scientific process and help de-risk development at every stage. Our collective services include:

  • Synthetic chemistry services, including custom lipids and carbohydrates, hit to lead and lead optimization, process research and development, route scouting and selection, inventory management, and structure-activity relationships.

  • Biology-focused preclinical discovery services, including target identification and validation, assay design and development, cell-based assay services, mechanism of action studies, target screening services, and custom protein and antibodies.

  • Preclinical CRO services, including expert consulting, in-vitro ADME, formulation development, physicochemical characterization, preclinical PK, efficacy, and exploratory toxicology, non-GLP and GLP bioanalysis, and SBIR support.

Each partner brings a core strength, and together, we complete the science.

 

Why Choose the A2 BioPharm Collaborative?

  • We offer unified communication, shared milestones, and a deep understanding of how to move a preclinical program forward efficiently and responsibly.

  • Our scientific teams are composed of industry veterans with decades of experience across discovery, preclinical research, and early development strategy.

  • Headquartered in the research hub of Ann Arbor, we are part of a growing life sciences ecosystem anchored by top academic institutions, clinical centers, and a talent-rich region.

  • Whether you are a startup with a breakthrough target or a Sponsor needing integrated preclinical execution, the A2 BioPharm Collaborative is built to plug in to your work seamlessly.

 

Meet the Collaborative

 

AAPharmaSyn provides superior synthetic chemistry services to global and regional pharmaceutical and biotechnology clients.

AnchorBio offers biology-focused preclinical discovery services to accelerate pharma and biotech R&D, diagnostics discovery, and development.

TSRL Inc. partners with entrepreneurs to develop drug products, offering expertise, preclinical development services, and access to non-dilutive funding opportunities.

 

Talk with the Collaborative

Have a project that is ready to move forward? Contact any of the partners directly or fill out the form below to learn how we can help bring your compound closer to clinic.